Neogenomics (NEO) PT Lowered to $18 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts NEO Hot Sheet
Price: $17.14 +1.84%
Rating Summary:
15 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
15 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Jefferies analyst Tycho Peterson lowered the price target on Neogenomics (NASDAQ: NEO) to $18.00 (from $22.00) while maintaining a Buy rating.
You May Also Be Interested In
- Clear Secure Inc (YOU) PT Raised to $80 at Goldman Sachs
- ArcBest Corp (ARCB) PT Lowered to $146 at TD Cowen
- Datadog (DDOG) PT Lowered to $230 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
